Our Healthcare Group is a leading provider of financing and strategic advice to large and established enterprises as well as to earlier-stage growth companies in the healthcare sector.

Mizuho's inventive ideas, deep industry knowledge and superior capital markets execution have made our firm a trusted advisor to companies in the Pharmaceutical, Biotech, Medical Devices and Healthcare Services Sectors.

Capital solutions for every stage of growth

In collaboration with Mizuho's product specialists and Financial Sponsors team, we have led high-profile M&A and acquisition-financing deals as well as growth-stage financings. We provide clients a full suite of capabilities, including debt and equity offerings, leveraged finance, risk-focused derivative solutions, strategic advisory, corporate finance and working capital solutions.


  • #3 in Investment Grade Healthcare (Dealogic, March 2023)




Notable Transactions

  • Active Bookrunner on Thermo Fisher’s $2.95 billion senior notes offering
  • Active Bookrunner and Billing & Delivery Agent on Medtronic’s $2 billion senior notes offering 
  • Active Bookrunner on Amgen’s $24 billion senior notes offering
  • Joint Bookrunner on Envista’s $500 million convertible notes offering
  • Joint Bookrunner on GE HealthCare’s $2.2 billion secondary offering




Industry expertise

  • Biotech
  • Pharma
  • Medical Devices
  • Healthcare Services
  • Life Sciences Tools & Diagnostics
Back to top